Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors (Q36385379)

13 August 2017

0 references

1 reference

title

Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors (English)

1 reference

13 August 2017

0 references

1 reference

1 reference

6

Kumanan Wilson

1 reference

13 August 2017

1

Edward J Mills

1 reference

13 August 2017

Dugald Seely

2

1 reference

13 August 2017

Beth Rachlis

3

1 reference

13 August 2017

Lauren Griffith

4

1 reference

13 August 2017

Ping Wu

5

1 reference

13 August 2017

Peter Ellis

7

1 reference

13 August 2017

James R Wright

8

1 reference

13 August 2017

publication date

1 February 2006

1 reference

Lancet Oncology Commission

13 August 2017

published in

1 reference

13 August 2017

volume

7

1 reference

13 August 2017

issue

2

1 reference

13 August 2017

page(s)

141-148

1 reference

Reasons for entry into and understanding of HIV/AIDS clinical trials: a preliminary study

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

Participation in cancer clinical trials: race-, sex-, and age-based disparities

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

Systematic review of barriers to the recruitment of older patients with cancer onto clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

Barriers to participating in an HIV vaccine trial: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

Systematic review of qualitative studies exploring parental beliefs and attitudes toward childhood vaccination identifies common barriers to vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

Systematically reviewing qualitative studies complements survey design: an exploratory study of barriers to paediatric immunisations

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

Focus group interviews examining attitudes to randomised trials among breast cancer patients and the general community

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

Patients' willingness to enter clinical trials: measuring the association with perceived benefit and preference for decision participation.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

Perceptions of equipoise are crucial to trial participation: a qualitative study of men in the ProtecT study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

How do doctors explain randomised clinical trials to their patients?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

Attitude of African-Americans regarding prostate cancer clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

Psychosocial aspects of participation in early anticancer drug trials. Report of a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

Study of the media's potential influence on prospective research participants' understanding of and motivations for participation in a high-profile phase I trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

Clinical trial participation. Viewpoints from racial/ethnic groups

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

Recruitment and retention of minority women in cancer screening, prevention, and treatment trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

Minority recruitment in clinical trials: a conference at Tuskegee, researchers and the community

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

Rural cancer patients' perspectives on clinical trials: a qualitative study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

Barriers to the participation of African-American patients with cancer in clinical trials: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

Attitudes toward clinical trials among patients and the public

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

Public attitudes toward participation in cancer clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

Attitudes to randomized clinical trials amongst out-patients attending a medical oncology clinic

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

Randomized clinical trials in oncology: understanding and attitudes predict willingness to participate.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

Informing breast cancer patients about clinical trials: a randomized clinical trial of an educational booklet

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

Attitudes of patients to randomised clinical trials of cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

Results of an intervention study to improve communication about randomised clinical trials of cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

Barriers to clinical trial participation by older women with breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

Clinical trials in cancer: the role of surrogate patients in defining what constitutes an ethically acceptable clinical experiment

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

Attitudes towards clinical research amongst participants and nonparticipants.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

An evaluation of barriers to accrual in the era of legislation requiring insurance coverage of cancer clinical trial costs in California

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

Perceptions of patients and physicians regarding phase I cancer clinical trials: implications for physician-patient communication.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

Volunteers or victims: patients' views of randomised cancer clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

Patient entry into randomized controlled trials of colorectal cancer treatment: factors influencing participation.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

What attitudes and beliefs underlie patients' decisions about participating in chemotherapy trials?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

What influences participation in clinical trials in palliative care in a cancer centre?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

Patient and physician attitudes toward breast cancer clinical trials: developing interventions based on understanding barriers

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

Differences in attitudes between patients with primary colorectal cancer and patients with secondary colorectal cancer: is it reflected in their willingness to participate in drug trials?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

New approach for recruitment into randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

The Value of Clinical Trials from a Patient Perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

Seeking informed consent to cancer clinical trials: describing current practice.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

Better reporting of harms in randomized trials: an extension of the CONSORT statement

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

The preferences of 600 patients for different descriptions of randomisation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

Discussing randomised clinical trials of cancer therapy: evaluation of a Cancer Research UK training programme

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

Enrollment of older persons in cancer trials after the medicare reimbursement policy change.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

Cancer trial enrollment after state-mandated reimbursement

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

Using meta ethnography to synthesise qualitative research: a worked example

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

Evaluating meta-ethnography: a synthesis of qualitative research on lay experiences of diabetes and diabetes care

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

Including qualitative research in systematic reviews: opportunities and problems

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

Rationale and standards for the systematic review of qualitative literature in health services research.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

Factors affecting uptake of childhood immunisation: a Bayesian synthesis of qualitative and quantitative evidence.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

Barriers to participation in HIV drug trials: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

The Challenge of Minority Recruitment in Clinical Trials for AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

Why Cancer Patients Enter Randomized Clinical Trials: Exploring the Factors That Influence Their Decision

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970576-9

7 January 2021

10.1016/S1470-2045(06)70576-9

Identifiers

DOI

1 reference

13 August 2017

1 reference